These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15473925)

  • 1. [Molecular mechanism of LRIG1 cDNA-induced apoptosis in human glioma cell line H4].
    Ye F; Guo DS; Niu HQ; Tao SZ; Ou YB; Lu YP; Lei T
    Ai Zheng; 2004 Oct; 23(10):1149-54. PubMed ID: 15473925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.
    Ye F; Gao Q; Xu T; Zeng L; Ou Y; Mao F; Wang H; He Y; Wang B; Yang Z; Guo D; Lei T
    J Neurooncol; 2009 Sep; 94(2):183-94. PubMed ID: 19300910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits glioma cell growth via targeting LRIG1.
    Liu L; Zhang Y; Zhu K; Song L; Tao M; Huang P; Pan Y
    J BUON; 2018; 23(2):403-409. PubMed ID: 29745084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation.
    Xie R; Yang H; Xiao Q; Mao F; Zhang S; Ye F; Wan F; Wang B; Lei T; Guo D
    Oncol Rep; 2013 Jan; 29(1):177-84. PubMed ID: 23124613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy study on bladder cancer with recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter].
    Yan ZJ; Cheng Y; Jiang JH; Hu JS; Shi XD
    Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):732-6. PubMed ID: 23157908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells.
    Zhang X; Song Q; Wei C; Qu J
    Cell Stress Chaperones; 2015 Jul; 20(4):631-41. PubMed ID: 25860915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of LRIG1 gene on the invasion of bladder cancer in vitro].
    Ye ZQ; Yan ZJ; Yang WM; Guo DS
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):258-61. PubMed ID: 17502024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity.
    Chang L; Shi R; Yang T; Li F; Li G; Guo Y; Lang B; Yang W; Zhuang Q; Xu H
    J Exp Clin Cancer Res; 2013 Dec; 32(1):101. PubMed ID: 24314030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2.
    Xiao Q; Tan Y; Guo Y; Yang H; Mao F; Xie R; Wang B; Lei T; Guo D
    PLoS One; 2014; 9(10):e111419. PubMed ID: 25353163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor.
    Kang CS; Pu PY; Li YH; Zhang ZY; Qiu MZ; Huang Q; Wang GX
    J Neurooncol; 2005 Sep; 74(3):267-73. PubMed ID: 16132520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway.
    Yang JA; Liu BH; Shao LM; Guo ZT; Yang Q; Wu LQ; Ji BW; Zhu XN; Zhang SQ; Li CJ; Chen QX
    Int J Clin Exp Pathol; 2015; 8(4):3580-90. PubMed ID: 26097540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of RNAi-mediated gene silencing of LRIG1 on proliferation and invasion of glioma cells.
    Mao F; Wang B; Xi G; Sun W; Zhang H; Ye F; Guo D; Lei T
    J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):227-232. PubMed ID: 22528225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1.
    Yi W; Holmlund C; Nilsson J; Inui S; Lei T; Itami S; Henriksson R; Hedman H
    Exp Cell Res; 2011 Feb; 317(4):504-12. PubMed ID: 21087604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
    Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
    Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro.
    Cheng SQ; Fan HY; Xu X; Gao WW; Lv SG; Ye MH; Wu MJ; Shen XL; Cheng ZJ; Zhu XG; Zhang Y
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):558-563. PubMed ID: 27465333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1.
    Fan H; Yuan R; Cheng S; Xiong K; Zhu X; Zhang Y
    Biomed Pharmacother; 2018 Jan; 97():1554-1563. PubMed ID: 29793318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LRIG1 promotes the apoptosis of pituitary tumor cells induced by cisplatin].
    Zhou L; Bao C; Hu X; Dai Y; Bao Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):9-15. PubMed ID: 29595451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line.
    Guo D; Han L; Shu K; Chen J; Lei T
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):91-4. PubMed ID: 17393120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.
    Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q
    Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of antisense and dominant-negative AKT2 constructs on proliferation of glioma cell line TJ905].
    Kang CS; Pu PY; Li J; Wang GX
    Ai Zheng; 2004 Nov; 23(11):1267-72. PubMed ID: 15522171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.